GGrantIndex
← Search

Production/Testing of a MVA Vaccine

$243,579N01FY2011AINIH

Sanofi Pasteur Biologics, Llc, Cambridge MA

Investigators

Abstract

The purpose of this contract is to support the advanced development and manufacture of a Modified Vaccinia Ankara (MVA) vaccine for smallpox.

View original record on NIH RePORTER →